2007
DOI: 10.1590/s1516-44462006005000049
|View full text |Cite
|
Sign up to set email alerts
|

Current clinical research environment: focus on psychiatry

Abstract: A b s t r a c tThe introduction of international guidelines on Good Clinical Practices (GCP) in 1996, immediately followed by the publication of Resolution CNS 196/96 in Brazil, created a great opportunity for Brazilian research centers to participate in international trials. Such studies must be strictly monitored in order to assure compliance with the regulations, as well as with the standards of patient safety. Clear agreement among the investigator, the sponsor and the institution carrying out the study m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Most trials were small and few involved more than one country. The value of international trials has been demonstrated in cancer, heart disease and perinatal care; such studies enable large numbers to be recruited [ 14 ], ensure wide generalisability of results [ 15 ] and facilitate research capacity building [ 16 ]. Conducting large international trials in mental health would be likely to have similar advantages.…”
Section: Discussionmentioning
confidence: 99%
“…Most trials were small and few involved more than one country. The value of international trials has been demonstrated in cancer, heart disease and perinatal care; such studies enable large numbers to be recruited [ 14 ], ensure wide generalisability of results [ 15 ] and facilitate research capacity building [ 16 ]. Conducting large international trials in mental health would be likely to have similar advantages.…”
Section: Discussionmentioning
confidence: 99%
“…18 This is of particular interest for the field of BD since most patients are treated by the public health system and prescription patterns may be different from the rest of the world, particularly regarding the use of atypical antipsychotics. 19 Despite being a leader in psychiatric research among developing countries, 20 one of the shortcomings that may constrain the progress of clinical research in Brazil is the relatively limited number of patients enrolled in most studies, and a natural step to overcome this limitation is to establish research networks. 21 In 2005, the Brazilian Association for Bipolar Disorder (ABTB) created the Brazilian Research Network in Bipolar Disorder (BRN-BD) as a means to promote the integration of BD research centers and to develop collaborative studies.…”
Section: Introductionmentioning
confidence: 99%